Corient Private Wealth’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$33.3K Buy
2025
Q1
$23.4K Hold
2024
Q4
$48.9K Hold
2024
Q3
$104K Hold
2024
Q2
$97.3K Sell
2024
Q1
$275K Buy
2023
Q4
$111K Sell
2023
Q3
$66.3K Buy
2023
Q2
$148K Sell
2023
Q1
$218K Buy
2022
Q4
$309K Buy